STOCK TITAN

[8-K] Biomea Fusion, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

West Bancorporation (WTBA) delivered a solid Q2 2025. Net income climbed to $7.98 million or $0.47 per share, a 54 % YoY surge as net interest income expanded 24 % to $21.4 million. The lift stemmed from a $3.8 million drop in interest expense while interest income held steady. Modest growth in non-interest revenue (+3 %) and tight cost control (+2 % expenses) pushed pre-tax income to $10.3 million (+62 %).

For the six-month period, earnings rose to $15.8 million ($0.94 EPS) from $11.0 million. Deposits increased $34.4 million to $3.39 billion, offsetting a $38.6 million contraction in the loan book to $2.97 billion. Cash and equivalents swelled to $345 million (+42 % YTD), boosting liquidity.

Credit metrics remain pristine: no non-accrual loans, no charge-offs and a stable $30.5 million ACL; credit-loss provision was zero. Equity improved to $240.9 million on stronger earnings and a $5.5 million recovery in AOCI, though unrealised AFS losses still total $83.8 million. The quarterly dividend was maintained at $0.25 per share.

West Bancorporation (WTBA) ha registrato un solido secondo trimestre 2025. L'utile netto è salito a 7,98 milioni di dollari o 0,47 dollari per azione, con un aumento del 54% su base annua, grazie a un'espansione del reddito netto da interessi del 24% che ha raggiunto 21,4 milioni di dollari. L'incremento è dovuto a una riduzione di 3,8 milioni di dollari nelle spese per interessi, mentre i ricavi da interessi sono rimasti stabili. Una modesta crescita dei ricavi non da interessi (+3%) e un rigoroso controllo dei costi (+2% nelle spese) hanno portato il reddito ante imposte a 10,3 milioni di dollari (+62%).

Nel semestre, gli utili sono saliti a 15,8 milioni di dollari (0,94 dollari per azione) da 11,0 milioni. I depositi sono aumentati di 34,4 milioni di dollari raggiungendo 3,39 miliardi di dollari, compensando una contrazione di 38,6 milioni di dollari nel portafoglio prestiti, che si è attestato a 2,97 miliardi di dollari. La liquidità è cresciuta grazie a un aumento della cassa e equivalenti a 345 milioni di dollari (+42% da inizio anno).

I parametri creditizi rimangono impeccabili: nessun prestito non produttivo, nessuna svalutazione e una copertura delle perdite su crediti (ACL) stabile a 30,5 milioni di dollari; la provision per perdite su crediti è stata pari a zero. Il patrimonio netto è migliorato a 240,9 milioni di dollari grazie a utili più solidi e a un recupero di 5,5 milioni di dollari nell'AOCI, anche se le perdite non realizzate su titoli disponibili per la vendita (AFS) ammontano ancora a 83,8 milioni di dollari. Il dividendo trimestrale è stato mantenuto a 0,25 dollari per azione.

West Bancorporation (WTBA) presentó un sólido segundo trimestre de 2025. El ingreso neto aumentó a 7,98 millones de dólares o 0,47 dólares por acción, un incremento interanual del 54%, impulsado por un crecimiento del ingreso neto por intereses del 24% hasta 21,4 millones de dólares. Este aumento se debió a una reducción de 3,8 millones de dólares en gastos por intereses, mientras que los ingresos por intereses se mantuvieron estables. Un modesto crecimiento en ingresos no relacionados con intereses (+3%) y un estricto control de costos (+2% en gastos) elevaron el ingreso antes de impuestos a 10,3 millones de dólares (+62%).

En el período de seis meses, las ganancias aumentaron a 15,8 millones de dólares (0,94 dólares por acción) desde 11,0 millones. Los depósitos crecieron 34,4 millones de dólares hasta 3,39 mil millones de dólares, compensando una contracción de 38,6 millones de dólares en la cartera de préstamos, que quedó en 2,97 mil millones de dólares. El efectivo y equivalentes aumentaron a 345 millones de dólares (+42% desde el inicio del año), mejorando la liquidez.

Los indicadores crediticios siguen siendo impecables: sin préstamos en mora, sin castigos y una provisión para pérdidas crediticias (ACL) estable en 30,5 millones de dólares; la provisión por pérdidas crediticias fue cero. El patrimonio mejoró a 240,9 millones de dólares gracias a ganancias más fuertes y una recuperación de 5,5 millones de dólares en AOCI, aunque las pérdidas no realizadas en valores disponibles para la venta (AFS) aún suman 83,8 millones de dólares. El dividendo trimestral se mantuvo en 0,25 dólares por acción.

West Bancorporation(WTBA)는 2025년 2분기에 견고한 실적을 기록했습니다. 순이익은 7.98백만 달러 또는 주당 0.47달러로 전년 동기 대비 54% 증가했으며, 순이자수익은 24% 증가한 21.4백만 달러를 기록했습니다. 이는 이자 비용이 3.8백만 달러 감소한 반면, 이자 수익은 안정적으로 유지된 결과입니다. 비이자 수익은 소폭 증가(+3%), 비용은 엄격히 통제되어(+2%) 세전 이익은 10.3백만 달러로 62% 증가했습니다.

6개월 기간 동안 순이익은 15.8백만 달러(주당 0.94달러)로 11.0백만 달러에서 증가했습니다. 예금은 34.4백만 달러 증가해 33.9억 달러에 달했으며, 대출 잔액은 38.6백만 달러 감소해 29.7억 달러가 되었습니다. 현금 및 현금성 자산은 3.45억 달러로 연초 대비 42% 증가해 유동성이 강화되었습니다.

신용 지표는 여전히 우수합니다: 부실 대출 없음, 대손상각 없음, 그리고 안정적인 30.5백만 달러의 대손충당금(ACL); 신용손실 충당금은 없었습니다. 자기자본은 강한 수익과 5.5백만 달러의 AOCI 회복으로 240.9백만 달러로 개선되었으나, 미실현 매도가능증권(AFS) 손실은 여전히 83.8백만 달러입니다. 분기 배당금은 주당 0.25달러로 유지되었습니다.

West Bancorporation (WTBA) a présenté un solide deuxième trimestre 2025. Le bénéfice net a augmenté pour atteindre 7,98 millions de dollars ou 0,47 dollar par action, soit une hausse de 54 % en glissement annuel, grâce à une croissance de 24 % du produit net d’intérêts, qui s’est élevé à 21,4 millions de dollars. Cette progression résulte d’une baisse de 3,8 millions de dollars des charges d’intérêts, tandis que les produits d’intérêts sont restés stables. Une croissance modeste des revenus hors intérêts (+3 %) et un contrôle strict des coûts (+2 % des dépenses) ont porté le résultat avant impôts à 10,3 millions de dollars (+62 %).

Sur la période de six mois, les bénéfices sont passés à 15,8 millions de dollars (0,94 dollar par action) contre 11,0 millions. Les dépôts ont augmenté de 34,4 millions de dollars pour atteindre 3,39 milliards de dollars, compensant une contraction de 38,6 millions de dollars du portefeuille de prêts, qui s’établit à 2,97 milliards de dollars. La trésorerie et les équivalents ont augmenté à 345 millions de dollars (+42 % depuis le début de l’année), renforçant la liquidité.

Les indicateurs de crédit restent impeccables : aucun prêt non productif, aucune radiation et une provision pour pertes sur prêts (ACL) stable à 30,5 millions de dollars ; la provision pour pertes sur crédits était nulle. Les capitaux propres se sont améliorés à 240,9 millions de dollars grâce à des bénéfices plus solides et à un redressement de 5,5 millions de dollars dans les autres éléments du résultat global (AOCI), bien que les pertes latentes sur les titres disponibles à la vente (AFS) s’élèvent toujours à 83,8 millions de dollars. Le dividende trimestriel a été maintenu à 0,25 dollar par action.

West Bancorporation (WTBA) lieferte ein solides zweites Quartal 2025 ab. Der Nettogewinn stieg auf 7,98 Millionen US-Dollar bzw. 0,47 US-Dollar je Aktie, ein Anstieg von 54 % im Jahresvergleich, da die Nettozinserträge um 24 % auf 21,4 Millionen US-Dollar zunahmen. Der Anstieg resultierte aus einem Rückgang der Zinsaufwendungen um 3,8 Millionen US-Dollar, während die Zinserträge stabil blieben. Ein moderates Wachstum der Nichtzinserträge (+3 %) und eine strenge Kostenkontrolle (+2 % bei den Aufwendungen) führten zu einem Vorsteuerergebnis von 10,3 Millionen US-Dollar (+62 %).

Für den Sechsmonatszeitraum stiegen die Gewinne auf 15,8 Millionen US-Dollar (0,94 US-Dollar pro Aktie) von 11,0 Millionen. Die Einlagen erhöhten sich um 34,4 Millionen US-Dollar auf 3,39 Milliarden US-Dollar und kompensierten eine Schrumpfung des Kreditportfolios um 38,6 Millionen US-Dollar auf 2,97 Milliarden US-Dollar. Die liquiden Mittel stiegen auf 345 Millionen US-Dollar (+42 % seit Jahresbeginn) und verbesserten die Liquidität.

Die Kreditkennzahlen bleiben einwandfrei: keine notleidenden Kredite, keine Abschreibungen und eine stabile 30,5 Millionen US-Dollar umfassende Rückstellung für Kreditverluste (ACL); die Kreditverlustrückstellung betrug null. Das Eigenkapital verbesserte sich auf 240,9 Millionen US-Dollar durch stärkere Gewinne und eine Erholung von 5,5 Millionen US-Dollar im AOCI, obwohl unrealisierte Verluste aus verfügbaren Wertpapieren (AFS) weiterhin 83,8 Millionen US-Dollar betragen. Die Quartalsdividende wurde mit 0,25 US-Dollar je Aktie beibehalten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR – Earnings beat driven by lower funding costs; credit quality pristine; balance-sheet growth muted.

Net interest margin expansion was the star: 24 % NII growth despite flat asset yields underscores successful deposit repricing and funding mix management. Operating leverage was positive, lifting ROA and EPS. Management preserved the dividend, signalling confidence. Loan contraction and heavier reliance on savings/MM deposits warrant monitoring, yet liquidity is ample given the $102 million YTD cash build. Unrealised AFS losses remain sizeable but improving; capital cushions look adequate. Overall, results should be viewed as incrementally positive for equity holders.

TL;DR – Credit risk extremely low; market-rate risk tied to large AOCI overhang persists.

Zero non-accruals, no charge-offs and stable ACL point to excellent asset quality. The watch-list exposure is minimal and migration trends benign. However, unrealised losses of $115 million on the AFS portfolio (-$83.8 million after tax) equal roughly 35 % of equity, keeping interest-rate risk elevated. Deposit mix shift from non-interest to interest-bearing accounts signals ongoing pricing pressure. Absence of provision builds is justified today, yet any macro weakening or rate volatility could quickly erode capital. Impact is moderately positive but vigilance on rate risk remains essential.

West Bancorporation (WTBA) ha registrato un solido secondo trimestre 2025. L'utile netto è salito a 7,98 milioni di dollari o 0,47 dollari per azione, con un aumento del 54% su base annua, grazie a un'espansione del reddito netto da interessi del 24% che ha raggiunto 21,4 milioni di dollari. L'incremento è dovuto a una riduzione di 3,8 milioni di dollari nelle spese per interessi, mentre i ricavi da interessi sono rimasti stabili. Una modesta crescita dei ricavi non da interessi (+3%) e un rigoroso controllo dei costi (+2% nelle spese) hanno portato il reddito ante imposte a 10,3 milioni di dollari (+62%).

Nel semestre, gli utili sono saliti a 15,8 milioni di dollari (0,94 dollari per azione) da 11,0 milioni. I depositi sono aumentati di 34,4 milioni di dollari raggiungendo 3,39 miliardi di dollari, compensando una contrazione di 38,6 milioni di dollari nel portafoglio prestiti, che si è attestato a 2,97 miliardi di dollari. La liquidità è cresciuta grazie a un aumento della cassa e equivalenti a 345 milioni di dollari (+42% da inizio anno).

I parametri creditizi rimangono impeccabili: nessun prestito non produttivo, nessuna svalutazione e una copertura delle perdite su crediti (ACL) stabile a 30,5 milioni di dollari; la provision per perdite su crediti è stata pari a zero. Il patrimonio netto è migliorato a 240,9 milioni di dollari grazie a utili più solidi e a un recupero di 5,5 milioni di dollari nell'AOCI, anche se le perdite non realizzate su titoli disponibili per la vendita (AFS) ammontano ancora a 83,8 milioni di dollari. Il dividendo trimestrale è stato mantenuto a 0,25 dollari per azione.

West Bancorporation (WTBA) presentó un sólido segundo trimestre de 2025. El ingreso neto aumentó a 7,98 millones de dólares o 0,47 dólares por acción, un incremento interanual del 54%, impulsado por un crecimiento del ingreso neto por intereses del 24% hasta 21,4 millones de dólares. Este aumento se debió a una reducción de 3,8 millones de dólares en gastos por intereses, mientras que los ingresos por intereses se mantuvieron estables. Un modesto crecimiento en ingresos no relacionados con intereses (+3%) y un estricto control de costos (+2% en gastos) elevaron el ingreso antes de impuestos a 10,3 millones de dólares (+62%).

En el período de seis meses, las ganancias aumentaron a 15,8 millones de dólares (0,94 dólares por acción) desde 11,0 millones. Los depósitos crecieron 34,4 millones de dólares hasta 3,39 mil millones de dólares, compensando una contracción de 38,6 millones de dólares en la cartera de préstamos, que quedó en 2,97 mil millones de dólares. El efectivo y equivalentes aumentaron a 345 millones de dólares (+42% desde el inicio del año), mejorando la liquidez.

Los indicadores crediticios siguen siendo impecables: sin préstamos en mora, sin castigos y una provisión para pérdidas crediticias (ACL) estable en 30,5 millones de dólares; la provisión por pérdidas crediticias fue cero. El patrimonio mejoró a 240,9 millones de dólares gracias a ganancias más fuertes y una recuperación de 5,5 millones de dólares en AOCI, aunque las pérdidas no realizadas en valores disponibles para la venta (AFS) aún suman 83,8 millones de dólares. El dividendo trimestral se mantuvo en 0,25 dólares por acción.

West Bancorporation(WTBA)는 2025년 2분기에 견고한 실적을 기록했습니다. 순이익은 7.98백만 달러 또는 주당 0.47달러로 전년 동기 대비 54% 증가했으며, 순이자수익은 24% 증가한 21.4백만 달러를 기록했습니다. 이는 이자 비용이 3.8백만 달러 감소한 반면, 이자 수익은 안정적으로 유지된 결과입니다. 비이자 수익은 소폭 증가(+3%), 비용은 엄격히 통제되어(+2%) 세전 이익은 10.3백만 달러로 62% 증가했습니다.

6개월 기간 동안 순이익은 15.8백만 달러(주당 0.94달러)로 11.0백만 달러에서 증가했습니다. 예금은 34.4백만 달러 증가해 33.9억 달러에 달했으며, 대출 잔액은 38.6백만 달러 감소해 29.7억 달러가 되었습니다. 현금 및 현금성 자산은 3.45억 달러로 연초 대비 42% 증가해 유동성이 강화되었습니다.

신용 지표는 여전히 우수합니다: 부실 대출 없음, 대손상각 없음, 그리고 안정적인 30.5백만 달러의 대손충당금(ACL); 신용손실 충당금은 없었습니다. 자기자본은 강한 수익과 5.5백만 달러의 AOCI 회복으로 240.9백만 달러로 개선되었으나, 미실현 매도가능증권(AFS) 손실은 여전히 83.8백만 달러입니다. 분기 배당금은 주당 0.25달러로 유지되었습니다.

West Bancorporation (WTBA) a présenté un solide deuxième trimestre 2025. Le bénéfice net a augmenté pour atteindre 7,98 millions de dollars ou 0,47 dollar par action, soit une hausse de 54 % en glissement annuel, grâce à une croissance de 24 % du produit net d’intérêts, qui s’est élevé à 21,4 millions de dollars. Cette progression résulte d’une baisse de 3,8 millions de dollars des charges d’intérêts, tandis que les produits d’intérêts sont restés stables. Une croissance modeste des revenus hors intérêts (+3 %) et un contrôle strict des coûts (+2 % des dépenses) ont porté le résultat avant impôts à 10,3 millions de dollars (+62 %).

Sur la période de six mois, les bénéfices sont passés à 15,8 millions de dollars (0,94 dollar par action) contre 11,0 millions. Les dépôts ont augmenté de 34,4 millions de dollars pour atteindre 3,39 milliards de dollars, compensant une contraction de 38,6 millions de dollars du portefeuille de prêts, qui s’établit à 2,97 milliards de dollars. La trésorerie et les équivalents ont augmenté à 345 millions de dollars (+42 % depuis le début de l’année), renforçant la liquidité.

Les indicateurs de crédit restent impeccables : aucun prêt non productif, aucune radiation et une provision pour pertes sur prêts (ACL) stable à 30,5 millions de dollars ; la provision pour pertes sur crédits était nulle. Les capitaux propres se sont améliorés à 240,9 millions de dollars grâce à des bénéfices plus solides et à un redressement de 5,5 millions de dollars dans les autres éléments du résultat global (AOCI), bien que les pertes latentes sur les titres disponibles à la vente (AFS) s’élèvent toujours à 83,8 millions de dollars. Le dividende trimestriel a été maintenu à 0,25 dollar par action.

West Bancorporation (WTBA) lieferte ein solides zweites Quartal 2025 ab. Der Nettogewinn stieg auf 7,98 Millionen US-Dollar bzw. 0,47 US-Dollar je Aktie, ein Anstieg von 54 % im Jahresvergleich, da die Nettozinserträge um 24 % auf 21,4 Millionen US-Dollar zunahmen. Der Anstieg resultierte aus einem Rückgang der Zinsaufwendungen um 3,8 Millionen US-Dollar, während die Zinserträge stabil blieben. Ein moderates Wachstum der Nichtzinserträge (+3 %) und eine strenge Kostenkontrolle (+2 % bei den Aufwendungen) führten zu einem Vorsteuerergebnis von 10,3 Millionen US-Dollar (+62 %).

Für den Sechsmonatszeitraum stiegen die Gewinne auf 15,8 Millionen US-Dollar (0,94 US-Dollar pro Aktie) von 11,0 Millionen. Die Einlagen erhöhten sich um 34,4 Millionen US-Dollar auf 3,39 Milliarden US-Dollar und kompensierten eine Schrumpfung des Kreditportfolios um 38,6 Millionen US-Dollar auf 2,97 Milliarden US-Dollar. Die liquiden Mittel stiegen auf 345 Millionen US-Dollar (+42 % seit Jahresbeginn) und verbesserten die Liquidität.

Die Kreditkennzahlen bleiben einwandfrei: keine notleidenden Kredite, keine Abschreibungen und eine stabile 30,5 Millionen US-Dollar umfassende Rückstellung für Kreditverluste (ACL); die Kreditverlustrückstellung betrug null. Das Eigenkapital verbesserte sich auf 240,9 Millionen US-Dollar durch stärkere Gewinne und eine Erholung von 5,5 Millionen US-Dollar im AOCI, obwohl unrealisierte Verluste aus verfügbaren Wertpapieren (AFS) weiterhin 83,8 Millionen US-Dollar betragen. Die Quartalsdividende wurde mit 0,25 US-Dollar je Aktie beibehalten.

false 0001840439 0001840439 2025-07-22 2025-07-22
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 22, 2025

 

 

Biomea Fusion, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-40335   82-2520134

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1599 Industrial Road, San Carlos, CA   94070
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (650) 980-9099

900 Middlefield Road, 4th Floor Redwood City, CA 94063

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.0001 par value   BMEA   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 
 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Bihua Chen, as a Class I Director

On July 22, 2025, Bihua Chen informed the Board of Directors (the “Board”) of Biomea Fusion, Inc. (the “Company”) that she is resigning as a member of the Board and as chairperson of the Compensation Committee of the Board and member of the Nominating and Corporate Governance Committee of the Board, effective immediately. Ms. Chen’s resignation is not the result of any dispute or disagreement with the Company.

Appointment of Julianne Averill as a Class III Director

On July 22, 2025, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, appointed Julianne Averill as a member of the Board, effective as of July 22, 2025. The Board determined that Ms. Averill is independent under Nasdaq Listing Rule 5605(a)(2) and the Company’s corporate governance guidelines. Ms. Averill will serve as a Class III director with an initial term expiring at the Company’s 2027 annual meeting of stockholders. In connection with Ms. Averill’s appointment as a member of the Board, the Board also appointed her as a member of the Audit Committee of the Board.

As a non-employee director, Ms. Averill will receive cash compensation and equity awards for her Board service in accordance with the Company’s non-employee director compensation policy. In connection with her appointment, Ms. Averill received an option under the Company’s 2021 Equity Incentive Plan to purchase that number of shares of the Company’s common stock on July 22, 2025, the effective date of Ms. Averill’s appointment, with a Black-Scholes grant value of $360,000 (the “Initial Grant”). The Initial Grant will vest as to 1/36th of the underlying shares on a monthly basis over three years, subject to Ms. Averill’s continued service through each applicable vesting date.

There have not been any transactions since the beginning of the Company’s last fiscal year, nor are there any proposed transactions, in which the Company was or is to be a participant involving amounts exceeding $120,000 and in which Ms. Averill had or will have a direct or indirect material interest. There are no arrangements or understandings between Ms. Averill and the Company or any other persons pursuant to which Ms. Averill was appointed as a director of the Company. In addition, Ms. Averill will enter into an indemnification agreement with the Company consistent with the form of indemnification agreement entered into between the Company and its existing non-employee directors.

The Company issued a press release on July 24, 2025 announcing the appointment of Ms. Averill to the Board. A copy of this press release is furnished as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.
  

Description

99.1    Press Release issued by Biomea Fusion, Inc. on July 24, 2025.
104    Cover page interactive data file (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    BIOMEA FUSION, INC.
Date: July 24, 2025     By:  

/s/ Michael J.M. Hitchcock, Ph.D.

            Michael J.M. Hitchcock, Ph.D.
            Interim Chief Executive Officer
Biomea Fusion, Inc.

NASDAQ:BMEA

BMEA Rankings

BMEA Latest News

BMEA Latest SEC Filings

BMEA Stock Data

105.49M
51.35M
25.02%
63.55%
30.62%
Biotechnology
Pharmaceutical Preparations
Link
United States
REDWOOD CITY